At this point, you are effectively on a lower dose than prescribed, and the clinical effects reflect that reduction
Wegovy and Zepbound coverage for obesity depends heavily on the plan: Aetnas standard commercial PA criteria allow coverage with documentation, but a meaningful percentage of employer-sponsored plans have explicit carve-outs that exclude weight-loss drugs entirely
The patient was discharged after suture removal
Because GLP-1 medications are intended for long-term use, maintaining results will require ongoing diligence
Diabetes Care 34(Supplement_2):S279-84 Gerstein HC, Colhoun HM, Dagenais GR, Diaz R, Lakshmanan M, Pais P et al (2019) Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial
Role of the adipocyte, free fatty acids, and ectopic fat in pathogenesis of type 2 diabetes mellitus: peroxisomal proliferator-activated receptor agonists provide a rational therapeutic approach